Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 7.62B 1.13B 970M 908M 831M 1.56B 108B 1.58B 10.73B 4.18B 54.45B 4.25B 4.16B 180B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 5.12B 762M 653M 611M 559M 1.05B 72.92B 1.06B 7.22B 2.81B 36.63B 2.86B 2.8B 121B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day-4.26%
1 week-3.48%
Current month-3.55%
1 month-1.29%
3 months+1.09%
6 months-6.92%
Current year-11.71%
1 week 12.88
Extreme 12.88
13.74
1 month 12.88
Extreme 12.88
13.93
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
16.42
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 44 06/01/2019
Director of Finance/CFO 49 05/12/2021
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 25/03/2014
Director/Board Member 64 25/09/2017
Director/Board Member 44 25/09/2017
Date Insider Type Main position Quantity % Market Cap.
17/07/24 Buy 500 0.0001%
22/01/20 Sell

Director

246,300 0.0462%
01/01/20 Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
-4.26%-3.48%-19.75%-41.76% 1.13B
-1.75%-1.40%-14.42%-5.44% 13.09B
-2.74%-2.90%-35.91%-57.41% 4.85B
-6.30%-6.88%-7.32%-5.58% 4.59B
-5.35%-3.01%+1.29%-28.48% 4.09B
-2.56%-2.27%-24.04%+0.57% 3.51B
-2.87%-0.49%-11.37%-7.54% 3.34B
-3.23%-2.35%-12.30%+11.55% 3.33B
-4.14%-2.45%-18.19%-15.33% 2.43B
-3.92%-3.50%-30.34%-14.40% 1.67B
Average -3.71%-2.65%-17.24%-16.38% 4.2B
Weighted average by Cap. -3.28%-2.34%-15.98%-13.92%

Financials

2024 2025
Net sales 3.38B 502M 430M 403M 369M 692M 48.07B 701M 4.76B 1.86B 24.15B 1.89B 1.85B 79.86B 2.32B 345M 295M 276M 253M 475M 32.99B 481M 3.27B 1.27B 16.57B 1.29B 1.27B 54.82B
Net income 492M 73.19M 62.7M 58.67M 53.7M 101M 7B 102M 693M 270M 3.52B 275M 269M 11.64B -258M -38.35M -32.85M -30.74M -28.14M -52.81M -3.67B -53.51M -363M -142M -1.84B -144M -141M -6.1B
Net Debt -2.29B -341M -292M -273M -250M -469M -32.59B -475M -3.23B -1.26B -16.37B -1.28B -1.25B -54.14B -2.49B -371M -318M -297M -272M -510M -35.47B -517M -3.51B -1.37B -17.82B -1.39B -1.36B -58.94B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
21/08/26 CN¥13.04 -4.26% 8,299,605
20/08/26 CN¥13.62 +2.71% 7,289,628
19/08/26 CN¥13.26 -0.30% 4,709,494
18/08/26 CN¥13.30 -0.30% 5,098,473
17/08/26 CN¥13.34 -1.26% 7,537,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock